2nd International Conference and Exhibition on Cancer & Therapeutics
Nov 26-28, 2018 , San Diego, USA
Conference Updates
committee
Members
Alain L Fymat
CEO and Professor
Dr. Alain L Fymat is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California).He is Editor-in-Chief, Honorable Editor or Editor of 12 scientific Journals.
He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles with double doctorate degrees.
Dr. Fymat’s current research interests lie at the interface between science and medicine, including Nanomedicine, Molecular/personal/precision medicine, Human genetics/ epigenetics/ ecogenetics, and Pharmacogenomics. Regarding cancer/oncology, his interests are in:
- Nanooncology
- Nanochemotherapy
- Cancer electrotherapy
- Natural and synthetic immunotherapy
- Glioblastomas, brain tumors and neurodegenerative diseases.
He has extensively published 350 publications including patents,books & monographs, book chapters,refereed articles.His most recent publications deal with nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy,and drug delivery across the brain protective barriers.
- A. L. Fymat, Recent Research Developments in Anti-Cancer Therapy. J Cancer Prev Curr Res (Editorial) 2016, 5(2):1-2, 00155. DOI: 10.15406/ jcpcr.2016.05.00155, June 2016.
- A. L. Fymat, Nanotechnology and Cancer, J Cancer Prev Curr Res 2016, 5(6):1-7, 00180. DOI: 10.15406/jc1-pcr.2016.05.00180, September 2016.
- A. L. Fymat, The Long Quest for Cancer Cures, J Cancer Prev Curr Res (Editorial) 2016, 6(2):1-3, 00201. DOI: 10.15406/jcpcr.2016.06.00201, November 2016,
- A. L. Fymat, On Cancer Electro- and Nano-Chemotherapy, J Cancer Prev Curr Res (Perspective) 2017, 7(2):1-4:00232. DOI: 10.15406/jcpcr.2017.07.00232, January 2017.
- A. L. Fymat, Immunotherapy: An Emergent Anti-Cancer Strategy, J Cancer Prev Curr Res (Editorial) 2017, 7(3):1-4, 00233. DOI: 10.15406/jcpcr.2017.07.00233, February 2017.
- A. L. Fymat, Nanochemotherapy: An Emergent Anti-Cancer Modality, Global J Nanomed (Editorial) 2017, 1(1):555555. February 2017.
- A. L. Fymat, Nanoneurology: Drug Delivery Across the Brain Protective Barriers, J Nanomed Res 2017, 5(1):1-4, 00105. DOI: 10:5406/jnmr/2017.05.00105. February 2017.
- A.L. Fymat, Synthetic Immunotherapy with Chimeric Antigen Receptors, J Cancer Prev Curr Res 2017, 7(5):1-3, 00253: DOI:10.15406/jcpcr.2017.07.00253. April 2017.
- A.L. Fymat, Genetics, Epigenetics and Cancer, Cancer Therapy & Oncology Int J 2017, 4(2):555634. DOI: 10.19080/CTOIJ.2017.04.555634, April 2017.
- A. L. Fymat, Nanooncology: Perspective on Promising Anti-Tumor Therapies, J Tumor Medicine & Prevention 2017, 1(1):1-10, 1-10, 555555, April 2017.
- A. L. Fymat, Disrupting Cell Mitoses to Provoke Cancer Self-Destruction, Cancer Therapy & Oncology Int J 2017 5(1):1-3, 555655. DOI: 10.19080/CTOIJ.2017.05.555655, May 2017.
- A. L. Fymat, Anti-Tumor Therapies - Cases of Breast and Prostate Cancers, J Tumor Medicine & Prevention 2017 1(2)1-12, 555559, June 2017.
- A. L. Fymat, Therapeutics Delivery Behind, Through and Beyond the Blood Brain Barrier, Open Access Journal of Surgery 2017; 5(1): 1-8; 555654. DOI: 10.19080/OAJS.2017.05.555654. June 2017.
- A.L. Fymat, Glioblastoma Therapies: Where Do We Stand? MedPlus Journal of Oncology, August 1(1)112, August 2017.
- A. L. Fymat, On Cancer's Theories, True Nature, and Possible Self-Eradicating Process, Cancer Therapy and Oncology Int J, 7(2):1-3, DOI: 10.19080/CTOIJ.2017.07.555709, October 2017.
Register Now
Highlights
Brochure
